Re: FDA approves Vraylar - 97 week phase III study

Posted by Lamdage22 on September 20, 2015, at 13:57:33

In reply to Re: FDA approves Vraylar - 97 week phase III study » SLS, posted by Tomatheus on September 20, 2015, at 13:51:31

I am concerned about movement disorders.
supposedly schizo-affective, type depressive
Seroquel 700mg
Zyprexa 12.5mg
Lithium orotate 360mg
Metformin 2425mg
Effexor 37.5mg

Thread

FDA approves Vraylar for schizophrenia, bipolar Tomatheus 9/17/15
...
Re: Medscape 6 phyciatrists comments » Tomatheus Phillipa 9/17/15
Re: FDA approves Vraylar for schizophrenia, bipolar SLS 9/17/15
Re: FDA approves Vraylar for schizophrenia, bipolar » SLS Tomatheus 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar Lamdage22 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar Christ_empowered 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Lamdage22 Tomatheus 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Christ_empowered Tomatheus 9/18/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Tomatheus herpills 9/19/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Christ_empowered herpills 9/19/15
Re: FDA approves Vraylar for schizophrenia, bipolar Lamdage22 9/20/15
FDA approves Vraylar - 97 week phase III study SLS 9/20/15
Re: FDA approves Vraylar - 97 week phase III study » SLS Tomatheus 9/20/15
Re: FDA approves Vraylar - 97 week phase III study Lamdage22 9/20/15
Re: FDA approves Vraylar for schizophrenia, bipolar Lamdage22 9/20/15
Re: FDA approves Vraylar for schizophrenia, bipolar » Lamdage22 Tomatheus 9/20/15
Re: FDA approves Vraylar - 97 week phase III study » Tomatheus SLS 9/20/15
Re: FDA approves Vraylar - 97 week phase III study Lamdage22 9/21/15

Post a new follow-up

Notify the administrators

Start a new thread

poster:Lamdage22 thread:1082598
URL: http://www.dr-bob.org/babble/20150901/msgs/1082737.html

	for
in